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Introduction
Complex regional pain syndrome (CRPS) is a painful, disabling and often chronic condition with an estimated 50,000 new cases in the US each year. 7 Evidence from CRPS patients and human volunteers suggest that both sensory primary afferent c-fibers and sympathetic neurons function aberrantly in CRPS, resulting in vascular symptoms, trophic changes and pain. 4, 5, 30 Additional studies measuring cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) have demonstrated that these mediators are elevated in the experimental skin blister fluid of CRPS patients, 11, 17, 19, 31 as is tryptase, a marker for mast cells capable of releasing a host of nociceptive and vasoactive mediators. 21 Furthermore, TNF-α levels are increased in CRPS skin biopsies when measured by enzyme immunoassay and in CRPS affected hands scintigraphically imaged with radiolabeled anti-TNF-α antibody. 1, 24 Population based studies indicate that distal limb fracture is the most common cause of CRPS 7, 37 and we have developed a distal tibia fracture model in rats and mice that closely parallels the regional changes observed in early CRPS, including hindlimb allodynia, unweighting, increased spinal Fos-immunoreactivity, increased skin temperature, edema, increased spontaneous protein extravasation, and periarticular bone loss. 12, 13, 29, 34, 35 Using the rat fracture model of CRPS, we have shown that facilitated substance P (SP) and calcitonin gene-related peptide (CGRP) signaling from sensory c-fibers, 44 as well as norepinephrine released from sympathetic nerve terminals, induce inflammation and pain sensitization by the activation of neuropeptide and adrenergic receptors on the surface of keratinocytes, causing keratinocytes to proliferate and secrete high levels of inflammatory cytokines and nerve growth factor (NGF), inflammatory mediators that contribute to pain behavior in this CRPS model. 14, 26, 27, 29, 34, 35, 39, 45 The release of SP from c-fibers also caused mast cell accumulation and degranulation, further contributing to pain behavior in the rat fracture M A N U S C R I P T
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model. 28 Based on these data, we postulate that post-traumatic up-regulated neuropeptide and sympathetic adrenergic signaling induces keratinocyte and mast cell activation, proliferation, and inflammatory mediator expression in CRPS skin. This investigation examined patient skin biopsies to determine whether keratinocyte and mast cell proliferation occurs in CRPS skin and to identify the cellular sources of the up-regulated TNF-α, IL-6, and tryptase previously observed in CRPS experimental skin blister fluid and skin biopsies. 
Methods
Subjects and clinical data collection
The study protocols were approved by the respective local institutional review boards at Murdoch University and at the University of Mainz. Thirty-seven women (67%) and 18 men (33%) with CRPS were enrolled after giving written informed consent. The subjects' average age was 49.8 ± 1.8 years with a range of 20 to 72 years. Inclusion criteria included; 1) meeting the new IASP clinical diagnostic criteria for CRPS at the time of biopsy, 16 2) unilateral symptoms in the hand or foot, allowing use of the contralateral limb for the control biopsy, and 3) no recent glucocorticoid or bisphosphonate treatments (as these drugs potentially inhibit cytokine expression). Patient demographics and clinical data were recorded, including age, gender, CRPS duration and etiology, involved limb, pain medications, numerical 11 point pain score, allodynia, and limb temperature. Allodynia was tested by applying 3-4 light strokes with a small brush to the affected skin and asking patients if this evoked a normal or abnormal sensation. If the sensation was described as abnormal the patient was asked to give a qualitative description of the sensation. Descriptions of the brushing as uncomfortable or painful were regarded as allodynia. Patients were further tested by applying 3-4 light strokes to the skin with the tip of a paper clip and if the patient described that stimulation as uncomfortable or painful the response was also categorized as allodynia. Limb temperature was also measured over 5 separate sites in the affected skin and over the mirror-image area of the contralateral healthy limb, using an infrared skin thermometer (Tempett IR Thermometer, Somedic or Fluke IR Thermometer No 561, Fluke), and the difference between the averaged values in the CRPS affected limb-the contralateral limb was calculated.
Tissue processing and microscopy
Under local anesthesia full thickness 3mm skin punch biopsies were obtained from the bilateral hands or feet of 55 CRPS patients. The biopsies were collected from the same location bilaterally in
each patient, so that the normal (unaffected) side control biopsy was the mirror image of the affected side skin biopsy. Biopsies were fixed in Zamboni's fixative (FD NeuroTechnologies) for 4 hours at 4°C, then rinsed with 0.1M PB (pH 7.4) and 50% ethanol followed by embedding in TissurePrep2 paraffin (Fisher Scientific). Following embedding 8-10µM slices were cut, mounted onto slides (Tru Scientific), deparaffinized in xylene, hydrated through graded alcohols to distilled water. Paraffin sections were antigen-retrieved by IHC-Tek Epitope Retrieval Solution (IHC World) steaming for 40 minutes, then cooled to room temperature. Sections were permeabilized and blocked with PBS containing 10% donkey serum (Jackson ImmunoResearch Laboratories) and 0.3% Triton X-100, followed by exposure to primary antibodies overnight at 4°C in PBS containing 2% serum. Upon detection of the first antigen, primary antibody from a different species against the second antigen was applied to the sections and visualized using an alternative fluorophore-conjugated secondary antibody.
Sections were then rinsed in PBS and incubated with fluorophore-conjugated secondary antibodies against the immunoglobulin of the species from which the primary antibody was generated. After three washes, the sections were counterstained with DAPI (Thermo Fisher Scientific) solution (0.25µg/ml) to identify nuclei and mounted with anti-fade mounting medium (Invitrogen Molecular Probes). Images were obtained using confocal microscopy (Zeiss LSM/510 Upright 2 photon; Carl Zeiss) and stored on digital media. With regard to primary antibodies, rabbit anti human IL-6, 1:600 (Abcam), mouse monoclonal to human mast cell tryptase Ab-2, clone AA1, 1:1000 (Thermo Fisher Scientific), mouse
slices in primary and secondary antibody-free solutions both of which led to low intensity non-specific staining patterns in preliminary experiments (data not shown).
For the detection of TNF-α expression in the epidermal keratinocytes, a mouse monoclonal antibody to human TNF-α, clone 2C8 (Meridian Life Sciences, Inc.) was labeled with Alexa Fluor 555 microscale protein labeling kit (Invitrogen Molecular Probes) under optimum conditions according to the manufacture's protocol, and quantified using a NanoDrop ND-1000 UV-Vis spectrophotometer (Thermo Fisher Scientific). The concentration of purified protein conjugate was 0.31 mg/ml. Then an equal volume of glycerol (ACS grade) was added for a final concentration of 50%, and stored at -20 0 C as a liquid. Upon detection of the keratin as described above, 250 µl of a 1:350 dilution of the conjugate was used for the TNF-α immunostaining.
Quantitative studies and statistical analysis
To assess the differences in epidermal skin thickness between the healthy (unaffected) and affected sides in CRPS patients, a pan-keratinocyte marker recognizing both the acidic and basic (Type 1 and II) subfamilies of cytokeratins was used to label keratinocytes and fluorescent immunohistochemistry and confocal microscopy were performed as previously described. 27 Epidermal thickness measurements were made using LSM Image Browser from Zeiss LSM Data Server. A blinded observer selected 4 to 8 sections from each skin biopsy and 4 to 8 thickness measurements were made in each section to derive a mean score for that biopsy. The individual mean scores were then used to calculate the mean thickness and S.E.M. for the healthy limbs and the affected limbs for all patients. To evaluate keratinocyte proliferation the nuclear proliferation marker protein Ki-67, which is expressed in cells undergoing the S/G2/M transition, was immunostained in skin sections previously labeled for keratin. variables (epidermal thickness differences, Ki-67 labeled cell number differences, tryptase labeled cell number differences, numerical pain scores, skin temperature differences, patient age, and duration of CRPS) were tested by Spearman rank-order correlation due to skewed distributions. Relationships between interval variables and dichotomous variables (allodynia, fracture, CRPS I and II, and gender)
were tested by point biserial correlation analysis. All data are presented as the mean ± standard error of the mean, and differences are considered significant at a P value less than 0.05 (Prism 6, GraphPad Software). Table 1 presents the demographics and clinical presentation of the patients evaluated in this study. The majority (67%) of the subjects were female, the average age was 49.4 ± 1.8 years, and the median duration of CRPS was 16 (3-920) weeks. The average numerical pain score on an 11-point scale was 6.4 ± 0.3 at the time of biopsy and allodynia was present in 48% of patients. The average skin temperature difference between the affected limb and the contralateral healthy limb was 0 ± 0.2°. Biopsies were obtained bilaterally from the hands in 45 patients and from the feet in 10 patients. Distal limb fracture was the most common etiology of CRPS, accounting for 38% of patients. CRPS type I accounted for 80% of patients and type II for 20%.
Results
Patient demographics and clinical presentation
Based on our prior analysis of 145 CRPS patients demonstrating increased edema and warmth in acute CRPS versus chronic CRPS, 3 and the inverse correlation between CRPS duration and epidermal thickness, number of Ki-67 labeled keratinocytes, and number of tryptase labeled mast cells (Table 2) , we separated the patients into 2 cohorts, acute (< 3 months CRPS duration, n = 26) and chronic (> 3 months CRPS duration, n = 29) CRPS. No differences were observed between the acute and chronic groups for any demographic or clinical presentation variable except for age. The average age for the acute group was 53.7 ± 2.9 years and for the chronic group it was 45.6 ± 2.0 years (p < 0.05).
The relationships between the interval variables (epidermal thickness differences, Ki-67 labeled cell number differences, tryptase labeled cell number differences, skin temperature differences, age, CRPS duration, and numerical pain scores) and the dichotomous variables (gender, limb, and the presence of allodynia, fracture, CRPS I, and CRPS II) were tested by point biserial correlation
analysis. The only significant correlations between dichotomous and interval variables were for
fracture and Ki-67 labeled cell number differences (49 ± 27 cells in fracture vs 8 ± 11 cells in no fracture, r = 0.37, p = 0.05), fracture and skin temperature differences (0.6 ± 0.3° in fracture vs -0.3 ± 0.2° in no fracture, r = 0.32, p < 0.05), and fracture and age (57.3 ± 2.6 years in fracture vs 43.9 ± 2.1 years in no fracture, r = 0.33, p < 0.05).
Keratinocyte proliferation in CRPS
To test the hypothesis that keratinocytes are activated and proliferating in CRPS affected skin, we performed immunostaining on sections from skin punch biopsies obtained from CRPS affected limbs, comparing the results to sections from biopsies obtained in the non-affected contralateral limb skin. A pan-keratinocyte marker recognizing the acidic and basic (Type 1 and II) subfamilies of cytokeratins was used to label epidermal keratinocytes ( Fig.1 ) and sections were co-stained for Ki-67 to determine keratinocyte proliferation (Fig. 2 ). As expected, there was a strong direct correlation between epidermal thickness and the number of keratinocytes co-labeled with the cellular proliferation marker Ki-67 (r = 0.72, p < 0.001, n = 34, Table 2 ). There was also a moderate inverse correlation between the duration of CRPS and epidermal thickness (r = -0.68, p < 0.001, n = 46), and a moderate direct correlation between the patient's age and epidermal thickness (r = 0.36, p < 0.05, n = 46). Similarly, there was a moderate inverse correlation between CRPS duration and the number of Ki-67 labeled keratinocytes (r = -0.49, p < .01, n = 40), and a moderate direct correlation between the patient's age and the number of Ki-67 labeled keratinocytes (r = 0.38, p < 0.05, n = 40). The correlations between epidermal thickness and Ki-67 labeled keratinocyte numbers with age may be attributable to an inverse correlation between age and the duration of CRPS (r = -0.38, p < 0.05, n = 55). Neither epidermal thickness nor Ki-67 labeled keratinocyte numbers correlated with tryptase labeled dermal cell numbers, numerical pain scales, or skin temperature differences.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
BIRKLEIN 11 Figure 1 illustrates that when the patients were separated into acute (< 3 months CRPS duration) and chronic (> 3months CRPS duration) groups there was a significant increase in epidermal thickness in the CRPS affected skin of the acute patient population and a decrease in epidermal thickness in the chronic patients. As shown in Figure 2 , in acute CRPS keratinocyte expression of Ki-67 was increased in CRPS affected skin, as compared to healthy skin from the contralateral limb, demonstrating keratinocyte hyperplasia. Conversely, in chronic CRPS keratinocyte Ki-67 expression was decreased in affected skin, compared to the contralateral side. Blinded subjective analysis suggested that in acute patients TNF-α immunostaining in CRPS affected skin was increased in 42%, decreased in 4%, and unchanged in 54% of patients, compared to the contralateral side. In chronic CRPS patients, TNF-α immunostaining in CRPS affected skin appeared increased in 25%, decreased in 14%, and unchanged in 61% of patients, compared to the contralateral side.
Keratinocyte expression of TNF-α and IL-6 in CRPS
Figure 4 presents representative photomicrographs illustrating increased IL-6 expression in the epidermal keratinocytes of the CRPS affected skin, compared to the contralateral side. Co-labeling with DAPI demonstrated that IL-6 immunoreactivity is localized in the keratinocyte cytoplasm. Blinded subjective assessment suggested that in acute patients IL-6 immunostaining in CRPS affected skin was increased in 39%, decreased in 0%, and unchanged in 61% of patients, compared to the contralateral side. In chronic CRPS patients, IL-6 immunostaining in CRPS affected skin appeared increased in 23%, decreased in 12%, and unchanged in 65% of patients, compared to the contralateral side.
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Mast cell accumulation in CRPS affected skin Figure 5 shows photomicrographs illustrating increased numbers of tryptase immunostained dermal mast cells in CRPS affected skin. There was a moderate inverse correlation between the duration of CRPS and the number of tryptase labeled cells (r = -0.45, p < 0.05, n = 27), and a moderate direct correlation between tryptase labeled cell numbers and skin temperature asymmetry (r = 0.47, p < 0.05, n = 24) ( Table 2 ). When patients were separated into acute and chronic cohorts, there was a significant increase in tryptase positive dermal mast cell numbers in the CRPS affected skin of the acute patient group and no changes in tryptase positive mast cell numbers in the CRPS affected skin of the chronic
Discussion
Previously we observed that 4 weeks after a distal tibia fracture in rats there was an increase in SP signaling in the injured limb, inducing keratinocyte activation and proliferation with a dramatic increase in hindpaw epidermal thickness. 27, 43, 44 The distal tibia fracture model in rats induces chronic vascular, inflammatory, nociceptive and boney changes in the injured hindlimb that closely parallel the clinical presentation of acute CRPS, 12, 13, 29, 34, 35 therefore, we hypothesized that skin keratinocyte proliferation and epidermal thickness would be increased in patients with acute CRPS.
In the current study there was a direct correlation between epidermal thickness and the number of Ki-67 labeled proliferating keratinocytes in the CRPS affected skin (Table 2 ). There was also an inverse correlation between the duration of CRPS and the epidermal thickness and the number of Ki-67 labeled proliferating keratinocytes in CRPS affected skin, indicating that epidermal thickening and increased keratinocyte proliferation were more prevalent early in the disease. When patients were separated into acute and chronic cohorts, epidermal thickness ( Fig. 1 ) and keratinocyte proliferation ( Fig. 2) were increased in the acute phase and decreased in the chronic phase. The changes observed in early CRPS patient skin confirm our previous observations of increased epidermal thickness and keratinocyte proliferation in the hindpaw skin at 4 weeks after tibia fracture in the rat. These results support the hypothesis that the rat fracture model might be utilized to predict novel pathophysiology in CRPS patients. We have not determined whether epidermal thickness or keratinocyte proliferation in the fracture rat model decline over time, but intend to pursue these questions in a future study. inflammatory mediators in CRPS skin include macrophages, monocytes, fibroblasts, and mast cells. 17 Previously we observed that TNF-α and IL-6 gene expression and protein levels are elevated in rat hindpaw skin at 4 weeks post-fracture and that keratinocytes are the primary source for the TNF-α and IL-6 observed in the fractured limb skin. 27, 29, 34 Based on these translational studies we predicted that the keratinocytes would be the primary source of up-regulated TNF-α and IL-6 expression in CRPS skin and the current study suggests that this is indeed the case (Figs. 3,4) . patients receiving a 6 week course of anti-TNF treatment. 9 The authors observed that anti-TNF treatment was more likely to be effective in early CRPS patients and in patients with warm affected extremities. Drickx et al recently published preliminary data from a discontinued randomized controlled trial that enrolled 6 CRPS patients treated with anti-TNF and 7 placebo treated controls.
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The data presentation in that paper did not allow the breakdown of results by duration of CRPS or limb warmth, but it appeared that at least one anti-TNF treated patient went from severe to moderate pain and none of the 7 placebo treated CRPS patients changed their categorical pain ratings.
Collectively, the preliminary results from these 4 reports suggest that some CRPS patients may have a dramatic response to anti-TNF treatment, particularly the subset of early CRPS patients with warm limbs.
Previously we observed that mast cell accumulation, activation, and degranulation increased in the hindpaw skin of tibia fracture rats at 4 weeks post-fracture and that mast cell degranulation contributes to pain sensitization in this CRPS model. 28 Based on these observations we predicted that there would be an increase in mast cell numbers in CRPS skin. In the current study there was an inverse correlation between the duration of CRPS and the number of tryptase labeled dermal mast cells in CRPS affected skin ( Table 2 ), indicating that increased mast cell numbers were more likely to be observed early in the disease. When patients were separated into acute and chronic cohorts, there was an increase in tryptase labeled mast cells in CRPS skin in the first 3 months of the disease and no change in mast cell numbers in chronic CRPS skin (Fig. 5) . These results suggest that increased dermal mast cell accumulation contributes to the elevated tryptase levels previously observed in experimental suction blister fluid from CRPS skin. 21 Those authors noted a significant correlation between blister fluid tryptase levels and the patient's pain intensity, suggesting that mast cell degranulation contributes to CRPS pain.
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inflammatory mediators, including tryptase, proteases, histamine, cytokines, and eicosanoids, all potentially capable of inducing inflammation and sensitization. In the current study we observed a direct correlation between mast cell numbers and skin temperature in the CRPS affected skin, consistent with histamine induced vasodilation ( Table 2 ).
There are several limitations of the current study. Bilateral skin biopsies were collected in patients with one CRPS affected limb, thus the contralateral limb biopsy was used as a control. It is unknown where the clinically uninvolved extremity may have exhibited keratinocyte or inflammatory changes.
Contralateral mirror limb changes in nociceptive processing and neurogenic inflammation have been observed in animal models after unilateral nerve and tissue injuries 15, 23 and increased substance P induced extravasation responses have been observed in the contralateral limb of CRPS patients. 25 Another concern is that the skin biopsies were obtained from CRPS patients recruited in Australia and
Germany and inflammatory responses can differ between races. 18, 32 Ethnicities of the CRPS patients
were not determined in the current study, thus potential differences in the Australian and German patient populations are a concern. Another limitation is there was no post-fracture (without CRPS) control group to look at the effects of trauma alone. In addition, there was a modest inverse correlation between the patient's age and the duration of CRPS, indicating a selection bias (Table 2 ). This patient selection bias for age and CRPS duration explains the modest direct correlation between patient age and epidermal thickness/keratinocyte proliferation, as CRPS duration directly correlated to epidermal thickness and keratinocyte proliferation ( Table 2 ). In normal subjects there is no correlation between age and epidermal thickness. 36 The strengths of the current study are; 1) the large number of bilateral CRPS patient biopsies obtained (n = 55), 2) the range of CRPS duration in these 55 patients allowed us to examine large numbers of both acute (< 3 month duration) and chronic (>3 month duration) patients, thus demonstrating changes in side-to-side differences in epidermal thickness, keratinocyte proliferation, and mast cell numbers over time, and 3) the use of bilateral skin biopsies in patients with a single CRPS M A N U S C R I P T
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affected extremity allowed the use of the contralateral "normal" limb as a control, thus compensating for age, gender, race, medications, and other medical co-morbidities.
Collectively, these results indicate that in early CRPS epidermal keratinocytes are activated in the affected skin, resulting in proliferation, epidermal thickening, and up-regulated TNF-α and IL-6 protein expression. In chronic CRPS patients keratinocyte proliferation is reduced with epidermal thinning. Acute CRPS patients also exhibit increased mast cell accumulation in the affected skin, RAMP1 receptor activity-modifying protein; NE, norepinephrine; β2-AR, β2 adrenergic receptor; IL-6, interleukin-6; IL-6R, IL-6 receptor; TNF α, tumor necrosis factor α TNF α R, TNF α receptor. Epidermal thickness, Ki-67 labeled cell number, tryptase labeled cell number, and temperature values represent the differences between the CRPS affected limb and the contralateral healthy limb. NPS, numerical pain score; Temp, temperature; *P < 0.05, **P < 0.01, ***P < 0.001
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